Abstract
The authors describe a sandwich immunosensor for anti-IgM T. cruzi-specific antibodies which are a biomarker for congenital Chagas disease (CCD). A screen-printed carbon electrode (SPCE) was modified with gold nanoparticles (AuNPs) and then functionalized with recombinant shed acute phase antigen (SAPA). The AuNPs/SPCE was characterized by scanning electron microscopy, cyclic voltammetry, and X-ray diffraction. The AuNPs provide an increased active surface area, high conductivity, and improved electrocatalytic characteristics, this resulting in a significant improvement of the detection limit. Following interaction between immobilized SAPA and the target antibodies in the serum sample, secondary antibody (an anti-human IgM-HRP conjugate) and solutions of H2O2 and 4-tert-butylcatechol were added and the enzymatic product was detected at −100 mV (vs. Ag/SPCE). The resulting current was proportional to the anti-T. cruzi IgM antibodies present in the sample and showed a linear trend from 10 to 200 ng mL−1 (R = 0.998). The detection limit was 3.03 ng mL−1. These values demonstrate that this electrochemical immunosensor can be used as an alternative serological method for diagnosis of congenital Chagas disease.

A screen printed carbon electrode was modified with gold nanoparticles functionalized with recombinant shed acute phase antigen (SAPA). The resulting biosensor was applied to the quantification of antibodies against anti-IgM T. cruzi that are biomarkers for congenital Chagas disease.
This is a preview of subscription content, access via your institution.






References
Praast G, Herzogenrath J, Bernhardt S, Christ H, Sickinger E (2011) Evaluation of the Abbott ARCHITECT Chagas prototype assay. Diagn Microbiol Infect Dis 69:74–81
Macedo C, Ferreira Larocca T, Noya-Rabelo M, Lemos Correia LC, Moreira MIG, Caldas AC, Torreão JA, de Freitas Souza BS, Ribeiro dos Santos R, Soares MBP (2015) Assessment of speckle tracking strain predictive value for myocardial fibrosis in subjects with Chagas disease. IJC Heart & Vasculature 8:75–80
Mello RP, Szarf G, Schvartzman PR, Nakano EM, Espinosa MM, Szejnfeld D, Fernandes V, Lima JAC, Cirenza C, De Paola AAV (2012) Delayed enhancement cardiac magnetic resonance imaging can identify the risk for ventricular tachycardia in chronic Chagas' heart disease. Arq Bras Cardiol 98:421–430
Gascon JA, Bern CB, Pinazo MJ (2009) Chagas disease in Spain, the United States and other non-endemic countries. Acta Tropica. 115:22–27
Lescure F, Paris L, Elghouzzi M, Le Loup G, Develoux M, Touafek F, Mazier D, Pialoux G (2009) Experience of targeted screening of Chagas disease in Ile-de-France. Bull Soc Pathol Exot Ses Fil 102:295–299
Bowling J, Walter E (2009) Recognizing and meeting the challenge of Chagas disease in the USA, Expert Rev. Anti-Infect Ther 7:1223–1234
Lescure FX, Le LG, Freilij H, Develoux M, Paris L, Brutus L, Pialoux G (2010) Chagas disease: changes in knowledge and management. Lancet Infect Dis 8:556–570
Pan American Health Organization (2004) “PAHO consultation on congenital chagas disease, its epidemiology and management” chagas’ disease: scientific and technical materials
Pan American Health Organization (2014) “Regional consultation on organization and structure of health care for the sick or infected with Trypanosomacruzi (Chagas’ disease)” Chagas’ disease: scientific and technical materials
Carlier Y, Truyens C, “Maternal-fetal transmission of Trypanosomacruzi” in American Trypanosomiasis–Chagas disease one hundred years of research, J. Telleria and M. Tibayrenc, Eds., 539–581, Elsevier, 2010.
Carlier Y, Truyens C, Deloron P, Peyron F (2012) Congenital parasitic infections: a review. Acta Trop 121:55–70
World Health Organization (2010) “Chagas disease: control and elimination” The Sixty-Third World Health Assembly WHA63.20. World Health Organization, Geneva, Switzerland
Basile L, Jansa JM, Carlier Y, Salamanca DD, Angheben A, Bartoloni A, Seixas J, Van Gool T, Canavate C, Flores-Chavez M, Jackson Y, Chiodini PL, Albajar-Vinas P (2011) Chagas disease in European countries: the challenge of a surveillance system. Euro Surveillance 16:19968
Camargo ME, Amato Neto V (1974) Anti-Trypanosomacruzi IgM antibodies as serological evidence of recent infection. Rev Inst Med Trop 16:200–202
Blanco SB, Segura EL, Cura EN, Chuit R, Tulian L, Flores I, Garbarino G, Villalonga JF, Gurtler RE (2000) Congenital transmission of Trypanosoma cruzi: an operational outline for detecting and treating infected infants in northwestern Argentina. Tropical Med Int Health 5:293–301
Carlier Y, Torrico F (2003) Congenital infection with Trypanosoma cruzi: from mechanisms of transmission to strategies for diagnosis and control. Conclusions of round tables and synopsis of an international colloquium. Rev Soc Bras Med Trop 36:767–771
Gurtler RE, Segura EL, Cohen JE (2003) Congenital transmission of Trypanosoma cruziinfection in Argentina. Emerg Infect Dis 9:29–32
Russomando G, Almiron M, Candia N, Franco L, Sanchez Z, de Guillen I (2005) Implementación y evaluación de un sistema localmente sustentable de diagnóstico prenatal que permite detectar casos de transmisión congénita de la enfermedad de Chagas en zonas endémicas del Paraguay. Rev Soc Bras Med Trop 3849–3854.
Oelemann WMR, Teixeira MGM, Verissimo-da-Costa GC, Borges-Pereira J, De Castro JA, Coura JR, Peralta JM (1998) Evaluation of three commercial enzyme-linked immunosorbent assays for diagnosis of Chagas’ disease. J Clin Microbiol 36:2423–2427
Saez-Alquézar A, Otani MM, Sabino EC, Ribeiro-dos-Santos G, Salles N, Chamone DF (1998) Evaluation of the performance of Brazilian blood banks in testing for Chagas’ disease. Vox Sang 74:228–231
Umezawa ES, Nascimento MS, Stolf AM (2001) Enzyme-linked immmunosorbent assay with T. cruziexcreted-secreted antigens (TESA ELISA) for serodiagnosis of acute and chronic Chagas’ disease. Diagn Microbiol Infect Dis 39:169–176
Umezawa ES, Bastos SF, Coura JR, Levin MJ, Gonzalez A, Rangel-Aldao R, Zingales B, Luquetti AO, Franco da Silveira J (2003) An improved serodiagnostic test for Chagas’ disease employing a mixture of Trypanosoma cruzi recombinant antigens. Transfusion 43:91–97
Flores-Chavez M, Bosseno MF, Bastrenta B, Dalenz JL, Hontebeyrie M, Revollo S, Brenière SF (2006) Polymerase chain reaction detection and serologic follow-up after treatment with benznidazole in Bolivian children infected with a natural mixture of Trypanosoma cruzi I and II. AmJTrop Med Hyg 75:497–401
Belluzo MS, Ribone ME, Camussone C, Marcipar IS, Lagier CM (2011) Favorably orienting recombinant proteins to develop amperometric biosensors to diagnose Chagas' disease. Anal Biochem 408:86–94
Reyes MB, Lorca M, Muñoz P, Frasch AC (1990) Fetal IgG specificities against Trypanosoma cruzi antigens in infected newborns. Proc Natl Acad Sci U S A 87:2846–2850
Marcipar IS, Lagier CM (2012) Advances in serological diagnosis of Chagas' disease by using recombinant proteins, current topics in tropical medicine, Dr. Alfonso Rodriguez-Morales (Ed.), ISBN: 978–953-51-0274-8, In Tech.
Diniz FB, Ueta RR, Pedrosa AM, AreiasMdaC PVR, Silva ED, da Silva JG, Ferreira AG, Gomes YM (2003) Impedimetric evaluation for diagnosis of Chagas' disease: antigen-antibody interactions on metallic electrodes. Biosens Bioelectron 19:79–84
Regiart M, Seia MA, Messina GA, Bertolino FA, Raba J (2014) Electrochemical immunosensing using a nanostructured functional platform for determination of α-zearalanol. Microchim Acta 182(3–4):531–538
Taleat Z, Khoshroo A, Mazloum-Ardakani M (2014) Screen-printed electrodes for biosensing: a review (2008-2013). Microchim Acta 181(9):865–891
Regiart M, Escudero LA, Aranda P, Martinez NA, Bertolino FA, Raba J (2015) Copper nanoparticles applied to the preconcentration and electrochemical determination of β-adrenergic agonist: An efficient tool for the control of meat production. Talanta 135:138–144
Welch C, Compton R (2006) The use of nanoparticles in electroanalysis: a review. Anal Bioanal Chem 384:601–611
Sanchez-Sus C, Martinez J, Guisantes JA (1986) Rev Iber Parasitol 46:105–108
Pereira SV, Bertolino FA, Fernández-Baldo MA, Messina GA, Salinas E, Sanz MI, Raba J (2011) A microfluidic device based on a screen-printed carbon electrode with electrodeposited gold nanoparticles for the detection of IgG anti-Trypanosoma cruzi antibodies. Analyst 136:4745–4751
Vasconcelos RHT, Azevedo EAN, Cavalcanti MGAM, Silva ED, Ferreira AGP, Morais CNL, Gomes YM (2011) Immunoglobulin M antibodies against CRA and FRA recombinant antigens of Trypanosoma cruzi in chronic chagasic patients. Hum Immunol 72:402–405
Acknowledgments
This work was supported by Universidad Nacional de San Luis (UNSL), Instituto de Química de San Luis (INQUISAL), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Agencia Nacional de Promoción Científica y Tecnológica (ANPCyT) and Fondo para la Investigación Científica y Tecnológica (FONCyT) - PICT-2013-2407.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare that they have no competing interests
Electronic supplementary material
ESM 1
(DOCX 43 kb)
Rights and permissions
About this article
Cite this article
Regiart, M., Pereira, S.V., Bertolino, F.A. et al. An electrochemical immunosensor for anti-T. cruzi IgM antibodies, a biomarker for congenital Chagas disease, using a screen-printed electrode modified with gold nanoparticles and functionalized with shed acute phase antigen. Microchim Acta 183, 1203–1210 (2016). https://doi.org/10.1007/s00604-016-1752-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00604-016-1752-4
Keywords
- Sandwich immunoassay
- Recombinant antigen
- Scanning electron microscopy
- Cyclic voltammetry
- X-ray diffraction
- Horseradish peroxidase
- Serology